Company page

Precision Biosciences, Inc.

Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.